NCT01742871

Brief Summary

Bleeding under vitamin K antagonists are a major iatrogenic causes of hospitalization, subject to a fatal outcome in more than one third of cases, mortality is particularly high in cases of serious bleeding, including intracerebral hemorrhage. If the INR measured in these patients are often away from the higher value of the target range, a significant proportion of bleeding were observed for INR between 2 and 3. The study captures the components of the nutritional status of patients on oral anticoagulants, including any micronutrient deficiencies, to determine whether nutritional status is an independent risk factor for bleeding

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 6, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

December 6, 2012

Status Verified

December 1, 2012

Enrollment Period

1.4 years

First QC Date

December 4, 2012

Last Update Submit

December 4, 2012

Conditions

Keywords

Antivitamin KBleedingHaemorrhageNutritional statusimpedancemetry

Outcome Measures

Primary Outcomes (1)

  • Denutrition diagnosis

    at day 1

Secondary Outcomes (9)

  • Zinc blood level

    at day 1

  • Cupper blood level

    at day 1

  • vitamin C blood level

    at day 1

  • vitamin B1 blood level

    at day 1

  • PINI (pronostic inflammatory and nutritional index)

    at day 1

  • +4 more secondary outcomes

Study Arms (2)

controls

Patient under anti-vitamin K with no haemorrhagic manifestations admitted for another reason to Emergency Adults

kaskadil

Patient under anti-vitamin K with a serious bleeding event that required treatment in the emergency Adults. Is considered serious accident requiring the use of a reversion by PPSB (Kaskadil ®).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Be included in this study patients under anti-vitamin K supported or followed the emergency department Adults.

You may qualify if:

  • Patients, male or female, aged over 18, under oral anticoagulant therapy with antivitamins K.
  • INR greater than 1.5, in the therapeutic range or overdose
  • Case-control study: patients under oral anticoagulant with severe hemorrhagic accident compared with patients without hemorrhagic accident. Cases will be matched to controls based on age, sex, and the value of INR :
  • Case:
  • Patients victims of serious hemorrhagic accident on VKAs, supported emergency Adults.
  • Will be considered severe hemorrhagic stroke, accidents requiring the use of a reversion by PPSB (Kaskadil ®)
  • Control :
  • Patients on VKAs supported the Emergency Adults for a reason other than bleeding.

You may not qualify if:

  • underage patients
  • Patients who have not read or understood nor signed the consent form or refusal of the reference person.
  • pregnant women
  • Patients with a pacemaker and / or implantable defibrillator
  • Patients with mechanical valve

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

RECRUITING

Related Publications (1)

  • Moustafa F, Dopeux L, Mulliez A, Boirie Y, Morand C, Gentes E, Farigon N, Richard D, Lebreton A, Teissandier D, Dutheil F, Schmidt J. Severe undernutrition increases bleeding risk on vitamin-K antagonists. Clin Nutr. 2021 Apr;40(4):2237-2243. doi: 10.1016/j.clnu.2020.10.002. Epub 2020 Oct 9.

MeSH Terms

Conditions

Hemorrhage

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2012

First Posted

December 6, 2012

Study Start

August 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

December 6, 2012

Record last verified: 2012-12

Locations